LAS VEGAS, Feb. 13, 2018 (GLOBE NEWSWIRE) — CV Sciences, Inc. (OTCQB:CVSI), preeminent manufacturer and distributor of hemp-derived phytocannabinoids including CBD oil, announced today that its industry dominating brand of finished products, PlusCBD Oil™ will be exhibiting at Natural Products Expo West on March 7-11, in Anaheim, California. Produced by New Hope Network, Natural Products Expo West is the leading trade show in the natural, organic and healthy products industry, attracting over 85,000 industry professionals and over 3000 exhibits to the Anaheim Convention Center.
PlusCBD Oil™, the #1 brand of hemp CBD products in the natural channel according to SPINS scan data, has achieved nationwide success since the launch of its brand of dietary supplements in 2014. The brand continues its fervent expansion in the natural products industry, with its products currently being sold in approximately 1500 independent health food stores and counting. “We all know that building trusted brands does not happen overnight. CV Sciences has spent the last 4 years nurturing natural products retailers and industry professionals about the promise of hemp based phytocannabinoids, particularly CBD, and setting the quality standard for other supplement brands entering this burgeoning category,” stated Stuart Tomc, VP of Human Nutrition and spokesperson for CV Sciences. “Natural Products Expo West is an incredible venue for new brands entering the industry and New Hope’s rigorous vetting process makes it clear from which quality brands to choose.”
NEW HOPE NETWORK CBD SUMMIT: CV Sciences is sponsoring New Hope Network’s first ever “CBD Summit,” held on Wednesday, March 7th from 8:30am to 12:30pm at the Marriott, Grand Ballroom F for Expo attendees interested in learning about the opportunities and challenges facing the hemp CBD market in the United States. CV Sciences’ Director of Business Development – Domestic Production will be presenting, “Made in America: Supply Chain Challenges,” at 9:30am. Conference Education badge is required for attendance. For more information, please visit The CBD Summit homepage.
VISIT BOOTH 4168 — SUPPLEMENTS: Attendees are invited to visit Booth #4168 in Level 1, Hall D – Supplements section where CV Sciences will be featuring PlusCBD Oil™ bulk and finished products. Learn more about the company, its brand, and products from any of the CV Sciences’ highly educated staff, who will be providing one-on-one education to retailers interested in carrying PlusCBD Oil™ products.
EXHIBITOR-SPONSORED PRESENTATION: Join the CV Sciences team for an interactive presentation, “Hemp CBD: A Staple for the Practice of Radical Self Care,” on Saturday, March 10th at 1:00pm in the Marriott, Platinum Ballroom 5. Presenters Maggie Frank and notable naturopathic physician, Dr. Aimée Shunney will explore the core beliefs around radical self-care and how the practice may be the key to enhancing overall well-being. Attendees will learn how hemp extracts, particularly hemp CBD, are important components in one’s nutritional toolbox in achieving Endocannabinoid System health. Finally, presenters will recommend a nutritional protocol for achieving self-care that can be applied at a retail level, including what to look for in a quality hemp extract brand.
SHOW SPECIALS: CV Sciences offers exclusive trade show discounts and show specials to retailers placing orders at the show. Discounts will be honored through the week following Expo West. Please see a CV Sciences associate for more information.
ABOUT CV SCIENCES
CV Sciences, Inc (OTCQB:CVSI), located in Las Vegas, Nevada, focuses on drug development activities on products containing cannabidiol (CBD) as the active pharmaceutical ingredient, and also is engaged in the sale of CBD, and the development, marketing and sale of end consumer products containing CBD, which is refined into its own PlusCBD Oil™ brand. Additional information is available from OTCMarkets.com or by visiting PlusCBDoil.com.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.
Robert Haag, Managing Director